NICE Approves Transformative Multiple Myeloma T...

By Rene Pretorius

June 16, 2025

Summary NICE has approved a novel combination therapy for multiple
Quantifying EU Medicine Access Challenges
Blinatumomab Benefit Assessment for ALL and Health Economics
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...
HTA Reform Analysis: Patterns and Global Trends in Health Technology Assessment
Implementing Health Technology Assessment in Oman
NICE Grants Conditional Robotic Surgery Approval to Enhance Patient Care and ...
Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefit...
Lenacapavir HIV Prevention: Approval and Access Strategy Updates
NICE Approves Gene Therapy for Sickle Cell: A Breakthrough in Treatment and H...
Streamlining HTA – Joint Scientific Consultations in the EU
Surrogate Endpoints Guidance: New International Report Enhances HTA Practices